[2]
Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes 2012; 3(6): 110-7.
[4]
Shah A, Kanaya AM. Diabetes and associated complications in the south asian population. Curr Cardiol Rep 2014; 16(5): 476.
[5]
Brennan E, McEvoy C, Sadlier D, Godson C, Martin F. The genetics of diabetic nephropathy. Genes 2013; 4(4): 596-619.
[6]
Toth-Manikowski S, Atta MG. Diabetic kidney disease: pathophysiology and therapeutic targets. J Diabetes Res 2015; 2015: 16.
[7]
Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005; (99): S57-65.
[8]
Crisan D, Carr J. Angiotensin I-converting enzyme: genotype and disease associations. JMD 2000; 2(3): 105-15.
[9]
Gumprecht J, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E. the End-Stage Renal Disease Study G. Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure. Kidney Int 2000; 58(2): 513-9.
[10]
Braliou GG, Grigoriadou A-MG, Kontou PI, Bagos PG. The role of genetic polymorphisms of the Renin–Angiotensin System in renal diseases: A meta-analysis. Comput Struct Biotechnol J 2014; 10(16): 1-7.
[11]
Mooyaart AL, Valk EJ, van Es LA, et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 2011; 54(3): 544-53.
[12]
Ding W, Wang F, Fang Q, Zhang M, Chen J, Gu Y. Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis. Mol Biol Rep 2012; 39(2): 1293-303.
[13]
Wang F, Fang Q, Yu N, et al. Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects. J Renin Angiotensin Aldosterone Syst 2012; 13(1): 161-74.
[14]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6(7): e1000097.
[15]
Kavvoura FK, Ioannidis JPA. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 2008; 123(1): 1-14.
[16]
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
[17]
Cochran WG. Some methods for strengthening the common chi-square test. Biometrics 1954; 10(4): 417-51.
[18]
Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene–disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008; 61(7): 634-45.
[19]
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629.
[20]
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50(4): 1088-101.
[21]
Wang Y, Peng W, Zhang X, et al. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. J Renin Angiotensin Aldosterone Syst 2016; 17(3): 1470320316666799.
[22]
Parchwani DN, Palandurkar KM, Hema Chandan Kumar D, Patel DJ. Genetic predisposition to diabetic nephropathy: evidence for a role of ACE (I/D) gene polymorphism in type 2 diabetic population from Kutch region. IJCB 2015; 30(1): 43-54.
[23]
Shaikh R, Shahid SM, Mansoor Q, Ismail M, Azhar A. Genetic variants of ACE (Insertion/Deletion) and AGT (M268T) genes in patients with diabetes and nephropathy. J Renin Angiotensin Aldosterone Syst 2014; 15(2): 124-30.
[24]
Kumar R, Sharma RK, Agarwal S. Genetic predisposition for development of nephropathy in type 2 diabetes mellitus. Biochem Genet 2013; 51(11-12): 865-75.
[25]
Shah VN, Cheema BS, Sharma R, et al. ACAC beta gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes. Mol Cell Biochem 2013; 372(1-2): 191-8.
[26]
Rahimi Z, Hasanvand A, Felehgari V. Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran. DNA Cell Biol 2012; 31(4): 553-9.
[27]
Al-Harbi EM, Farid EM, Gumaa KA, Masuadi EM, Singh J. Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population. Mol Cell Biochem 2011; 350(1-2): 119-25.
[28]
Jayapalan JJ, Muniandy S, Chan SP. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects. Indian J Hum Genet 2010; 16(2): 78-86.
[29]
Ahluwalia TS, Ahuja M, Rai TS, et al. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol 2009; 28(3): 141-50.
[30]
Naresh VVS, Reddy ALK, Sivaramakrishna G, Sharma PVGK, Vardhan RV, Kumar VS. Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy. Indian J Nephrol 2009; 19(4): 145-8.
[31]
Tien KJ, Hsiao JY, Hsu SC, et al. Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes. Am J Nephrol 2009; 29(4): 299-308.
[32]
Nikzamir A, Nakhjavani M, Golmohamadi T, Dibai L. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus. Arch Iran Med 2008; 11(1): 3-9.
[33]
Movva S, Alluri RV, Komandur S, et al. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J Diabetes Complications 2007; 21(4): 237-41.
[34]
Osawa N, Koya D, Araki S, et al. Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 2007; 52(2): 143-51.
[35]
Prasad P, Tiwari AK, Kumar KM, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet 2006; 7: 42.
[36]
So WY, Ma RC, Ozaki R, et al. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism. Kidney Int 2006; 69(8): 1438-43.
[37]
Park HC, Choi SR, Kim BS, et al. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med J 2005; 46(6): 779-87.
[38]
Ha SK, Park HC, Park HS, et al. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy. AKJD 2003; 41(5): 943-9.
[39]
Okuno S, Utsugi T, Ohno T, et al. Angiotensin-converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: a 9-year follow-up study. J Int Med Res 2003; 31(4): 290-8.
[40]
Lee YJ, Tsai JC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25(6): 1002-8.
[41]
Gohda T, Makita Y, Shike T, et al. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Clin Nephrol 2001; 56(6): 475-80.
[42]
Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M, Nishizawa Y. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 2001; 24(9): 1653-60.
[43]
Thomas GN, Critchley JA, Tomlinson B, et al. Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese. Clin Nephrol 2001; 55(1): 7-15.
[44]
Viswanathan V, Zhu Y, Bala K, et al. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP 2001; 2(2): 83-7.
[45]
Hsieh MC, Lin SR, Hsieh TJ, et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 2000; 15(7): 1008-13.
[46]
Kuramoto N, Iizuka T, Ito H, et al. Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. AJKD 1999; 33(2): 276-81.
[47]
Tomino Y, Makita Y, Shike T, et al. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 1999; 82(2): 139-44.
[48]
Wang J, Zhu X, Yang L, Liu Y, Zhou W, Li H. Relationship between angiotensinogen gene M235T variant with diabetic nephropathy in Chinese NIDDM. Chin Med J 1999; 112(9): 797-800.
[49]
Wong TY, Chan JC, Poon E, Li PK. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. AJKD 1999; 33(6): 1064-70.
[50]
Hanyu O, Hanawa H, Nakagawa O, et al. Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy. Ren Fail 1998; 20(1): 125-33.
[51]
Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy. Kidney Int 1998; 54(5): 1659-69.
[52]
Wu S, Xiang K, Weng Q, et al. Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy. Chin Med J 1998; 111(5): 478-9.
[53]
Young RP, Chan JC, Critchley JA, Poon E, Nicholls G, Cockram CS. Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients. Diabetes Care 1998; 21(3): 431-7.
[54]
Doi Y, Yoshizumi H, Yoshinari M, et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39(1): 97-102.
[55]
Nakajima S, Baba T, Yajima Y. Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients? Diabetes Care 1996; 19(12): 1420-2.
[56]
Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism Clin Exp 1996; 45(2): 218-22.
[57]
Yoshida H, Kuriyama S, Atsumi Y, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50(2): 657-64.
[58]
Mizuiri S, Hemmi H, Inoue A, et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70(4): 455-9.
[59]
Ma RCW, Chan JCN. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013; 1281(1): 64-91.
[60]
Shrivastava U, Misra A, Mohan V, Unnikrishnan R, Bachani D. Obesity, diabetes and cardiovascular diseases in India: public health challenges. Curr Diabetes Rev 2017; 13: 65-80.
[61]
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86(4): 1343-6.
[62]
Felehgari V, Rahimi Z, Mozafari H, Vaisi-Raygani A. ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria. Mol Cell Biochem 2011; 346(1-2): 23-30.
[63]
El-Baz R, Settin A, Ismaeel A, et al. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 2012; 13(4): 472-7.
[64]
Šeruga M, Makuc J, Završnik M, Cilenšek I, Ekart R, Petrovič D. Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus. Balkan J Med Genet 2016; 19(2): 29-34.
[65]
Arfa I, Abid A, Nouira S, et al. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 2008; 9(1): 32-6.
[66]
Haque SF, Ahmad M, Khan AU, Gupta V, Khan AS. Angiotensin converting enzyme insertion/deletion gene polymorphism and genomic sequence in diabetic nephropathy. Biomed Res 2011; 22(2): 175-9.
[67]
Patel HV, Kalia K, Mannari J. Angiotensin converting enzyme (ACE) gene polymorphism increases the susceptibility of diabetic nephropathy in Western Indian Type 2 diabetic patients. Int J Diabetes Dev Ctries 2011; 31(4): 223-8.
[68]
Bhaskar LV, Mahin S, Ginila RT, Soundararajan P. Role of the ACE ID and PPARG P12A polymorphisms in genetic susceptibility of diabetic nephropathy in a south Indian population. Nephrourol Mon 2013; 5(3): 813-7.
[69]
Zafarmand MH, van der Schouw YT, Grobbee DE, de Leeuw PW, Bots ML. The M235T polymorphism in the AGT gene and CHD risk: evidence of a hardy-weinberg equilibrium violation and publication bias in a meta-analysis. PLoS One 2008; 3(6): e2533.
[70]
Watkins WS, Rohrwasser A, Peiffer A, Leppert MF, Lalouel J-M, Jorde LB. AGT genetic variation, plasma AGT, and blood pressure: an analysis of the Utah Genetic Reference Project pedigrees. Am J Hypertens 2010; 23(8): 917-23.
[71]
Say Y-H, Ling K-H, Duraisamy G, Isaac S, Rosli R. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: A case control study. BMC Cardiovasc Disord 2005; 5(1): 7.
[72]
Mottl AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: A HuGE review. Genet Med 2008; 10(8): 560-74.
[73]
Moradi M, Rahimi Z, Amiri S, Rahimi Z, Vessal M, Nasri H. AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy. J Nephropathol 2015; 4(3): 69-76.
[74]
Makuc J, Šeruga M, Završnik M, Cilenšek I, Petrovič D. Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus. Bosn J Basic Med Sci 2017; 17(3): 262-7.
[75]
Reis KA, Ebinc FA, Koc E, et al. Association of the angiotensinogen M235T and APO E gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. Ren Fail 2011; 33(5): 469-74.
[76]
MacIsaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease . AJKD
63(2): S39-S62.
[77]
Yu ZY, Chen LS, Zhang LC, Zhou TB. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology 2012; 17(5): 480-7.
[78]
Ottman R. Gene–environment interaction: definitions and study designs. Prev Med 1996; 25(6): 764-70.
[79]
Salanti G, Southam L, Altshuler D, et al. Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol 2009; 170(5): 537-45.
